India Non Invasive Prenatal Testing Market To Foresee Commendable Growth of $ 62 Million by 2028

DELHI, India - July 4, 2022 - PRLog -- According to DPI Research Indian Non Invasive Prenatal Testing (NIPT) Market size is expected to reach USD 62 million by 2028. The market is expected to expand at a CAGR of more than 11% from 2022 to 2028.

India Non-Invasive Prenatal Testing Market is growing with the increasing per capita income, growing interest, increase in incidences of chromosomal aneuploidies among fetus, development of advanced non-invasive prenatal testing products, rising awareness regarding non-invasive prenatal testing. The market shows high potential for growth in the future.

This new market report presents a comprehensive study of the entire Indian non-invasive prenatal testing market. The report offers the most up–to–date industry data on the actual market situation and future outlook for the India non-invasive prenatal testing market. The report also provides up–to–date historical market size data for the period 2018 – 2021 and an illustrative forecast to 2028 covering key market aspects like market value and volume for non-invasive prenatal testing in India.

The Leading Companies for the Indian Non-Invasive Prenatal Testing Market are Listed Below:

• Medgenome
• DNA Labs India
• LifeCell
• Apollo Centre for Fetal Medicine
• Igenomix India
• Fortis Healthcare Limited
• DNA Forensics Laboratory Pvt. Ltd.
• Thyrocare Technologies Limited

For More Information@ https://dpiresearch.com/india-non-invasive-prenatal-testing-nipt-market/

The report is readily available and can be dispatched immediately after payment confirmation.

Would like to place an order or any question, please feel free to contact at sales@dpiresearch.com

Customization of the Report:

DPI Research provides customization of the report as per your need. This report can be personalized to meet your requirements. Get in touch with our sales team, who will guarantee you to get a report that suits your necessities.

Contact Us:
Maria Rai
Head of Business Development
DPI Research
Direct Line: +91-766-764-8693
E-mail: sales@dpiresearch.com